Skip to main content
Premium Trial:

Request an Annual Quote

Applied Precision Files for IPO

NEW YORK (GenomeWeb News) - Applied Precision filed for an initial public offering with the US Securities and Exchange Commission, the company said yesterday.
 
All shares of Applied Precision's common stock to be sold will be offered by the company. The number of shares to be offered and the price range have not yet been determined.
 
The underwriters of the offering will be CIBC World Markets. Cowen and Company and Canaccord Adams are co-managers, the company said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.